Zoetis Inc.
Zoetis Inc. (ZTS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ZTS · as of Jun 8, 2026
Key Statistics
Explore Zoetis Inc. Data
zts stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 30 · Buy rate: 50.0%
The ZTS analyst consensus is Hold, based on ratings from 30 Wall Street analysts over the past 3 months. The average 12-month price target is $125.71, representing +58.25% upside from the current price of $79.44.
Competitors & Peers
zts competitorsZTS
ARGX
BDX
CI
COR
ELANStock Performance
Full HistoryAbout Zoetis Inc.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primar…
what is zoetis inc. · zts stock overview · zoetis inc. company profile · who is zoetis inc. ceo · zts NYSE · zoetis inc. headquarters · zoetis inc. business segments
About Stock Overview & Key Data
Zoetis Inc. (ZTS) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since Feb 1, 2013. As of the latest trading session, ZTS stock price is $79.44, with a market capitalization of $33.3B. The stock has returned -51.74% over the past 12 months and -36.86% year-to-date.
According to 30 Wall Street analysts, the consensus rating for Zoetis Inc. stock is Hold, with an average 12-month price target of $125.71. In fiscal year 2025, Zoetis Inc. reported revenue of $9.5B and net income of $2.7B. For detailed data — including Zoetis Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Zoetis Inc. (ZTS) stock price is $79.44. The stock is traded on NYSE under the ticker symbol ZTS. The 52-week range is $72.38 – $171.52.